Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains. 2017

Ana-María Lacosta, and Daniel Insua, and Hassnae Badi, and Pedro Pesini, and Manuel Sarasa

The two pathognomonic lesions in the brain of AD patients are senile plaques and intraneuronal neurofibrillary tangles (NFT). Previous studies have demonstrated that amyloid-β (Aβ) is a component of both senile plaques and NFTs, and have showed that intracellular accumulation of Aβ is toxic for cells and precedes the appearance of extracellular amyloid deposits. Here we report that there are numerous intraneuronal NFT and extraneuronal NFT immunoreactive for Aβx-40 in which there is no co-localization with tau staining suggesting the existence of two different neurodegenerating populations associated with the intracellular accumulation of either tau protein or Aβx-40 in AD.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Ana-María Lacosta, and Daniel Insua, and Hassnae Badi, and Pedro Pesini, and Manuel Sarasa
May 1996, Neuroscience letters,
Ana-María Lacosta, and Daniel Insua, and Hassnae Badi, and Pedro Pesini, and Manuel Sarasa
May 2006, Neuroscience letters,
Ana-María Lacosta, and Daniel Insua, and Hassnae Badi, and Pedro Pesini, and Manuel Sarasa
September 2013, Bioorganic & medicinal chemistry,
Ana-María Lacosta, and Daniel Insua, and Hassnae Badi, and Pedro Pesini, and Manuel Sarasa
October 1998, European neurology,
Ana-María Lacosta, and Daniel Insua, and Hassnae Badi, and Pedro Pesini, and Manuel Sarasa
January 1989, Virchows Archiv. B, Cell pathology including molecular pathology,
Ana-María Lacosta, and Daniel Insua, and Hassnae Badi, and Pedro Pesini, and Manuel Sarasa
January 1998, Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University,
Ana-María Lacosta, and Daniel Insua, and Hassnae Badi, and Pedro Pesini, and Manuel Sarasa
March 1994, The Japanese journal of psychiatry and neurology,
Ana-María Lacosta, and Daniel Insua, and Hassnae Badi, and Pedro Pesini, and Manuel Sarasa
January 1990, Lancet (London, England),
Ana-María Lacosta, and Daniel Insua, and Hassnae Badi, and Pedro Pesini, and Manuel Sarasa
June 2001, Neuroscience letters,
Ana-María Lacosta, and Daniel Insua, and Hassnae Badi, and Pedro Pesini, and Manuel Sarasa
January 2012, ACS medicinal chemistry letters,
Copied contents to your clipboard!